Liye Wang

发表

BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review

Fei Xu, Shusen Wang, R. Hong, 2021, Oncology Research and Treatment.

Genetic Analysis of Oligo-Metastatic Breast Cancer: Correlation with Clinicopathological Features

Fei Xu, Qiufan Zheng, Shusen Wang, 2021 .

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population

Qiufan Zheng, Shusen Wang, R. Hong, 2019, Annals of medicine.

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study

X. An, Zhongyu Yuan, Jin-Chen Yu, 2021, Cancer communications.

Miller–Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy

Fei Xu, Shusen Wang, R. Hong, 2021, Frontiers in Oncology.

Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer

Fei Xu, Xiao Qiu, Liye Wang, 2020, Journal of Cancer.

Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer

Wei He, Shengli Zhang, Liye Wang, 2023, Scientific Reports.

Pre- and post-chemotherapy mutation status of epidermal growth factor receptor gene in non-small cell lung cancer

Meijuan Huang, Liye Wang, You Lu, 2011 .